SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-18-001116
Filing Date
2018-07-12
Accepted
2018-07-12 16:00:19
Documents
2
Period of Report
2018-07-03

Document Format Files

Seq Description Document Type Size
1 form3-07122018_040702.html 3  
1 form3-07122018_040702.xml 3 36790
2 ex99-07122018_040712.htm EX-99 15586
  Complete submission text file 0001415889-18-001116.txt   53679
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Issuer) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address
Biller Jonathan (Reporting) CIK: 0001744749 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34912 | Film No.: 18950488